15 Fastest Growing Biotech Companies in the US
Biotechnology is one of the most consequential domains of the healthcare industry.
Intellia Therapeutics Inc. (NTLA)
Market is closed
News
- First
- << Previous
- 61 - 69
Here's Why Intellia Therapeutics (NTLA) is Trading Higher Lately
Intellia Therapeutics Inc.
Is NTLA A Good Stock To Buy Now?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
Hedge Funds Have Never Been This Bullish On Intellia Therapeutics, Inc. (NTLA)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.
Here is What Hedge Funds Think About Intellia Therapeutics, Inc. (NTLA)
It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 4.8% during 2018 and average hedge fund losing...
13D Filing: OrbiMed Advisors and Intellia Therapeutics Inc (NTLA)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...
Is Intellia Therapeutics Inc (NTLA) A Good Stock To Buy?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.
Baker Bros. Opened Positions In These 5 Healthcare Stocks
Julian Baker and Felix Baker founded Baker Bros. Advisors in 2000.
10 Battered Biotech Stocks That Hit 52-Week Lows Friday
The markets have been strong over the past two weeks, bucking expectations that Britain's exit from the European Union would lead to a medium-term malaise in the market.
- First
- << Previous
- 61 - 69
Billionaire Hedge Funds
